ARTICLE | Company News
Sanofi cardiovascular news
March 25, 2013 7:00 AM UTC
Sanofi disclosed in its 2012 earnings that the U.S. Department of Justice is investigating "disclosures to the FDA regarding the variability of response to" cardiovascular drug Plavix clopidogrel. The pharma did not disclose details. ...